Quince Therapeutics shares rise 10.65% premarket after eliminating $16.4M EIB debt with $5.5M payment.

Wednesday, Apr 1, 2026 6:04 am ET1min read
QNCX--
Quince Therapeutics surged 10.65% in premarket trading following the announcement that it fully repaid approximately $16.4 million in outstanding debt to the European Investment Bank for about $5.5 million. The debt settlement, completed on March 27, 2026, is expected to enhance the company’s financial flexibility and reduce future obligations, likely contributing to the positive premarket reaction.

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet